Studies have demonstrated that BNP is a reliable biomarker not just for the systemic inflammation related to pneumonia, but also for quantifying the heart’s burden and predicting risk in affected patients (82). This evidence concerns the gene NPPB and susceptibility to pneumonia measurement.